US Market for Craniomaxillofacial Devices to Exceed $1.2 Billion by 2020, says the New Study on ASDReports

Wednesday 17 December 2014, Amsterdam

The US market for craniomaxillofacial (CMF) devices was valued at $803.5 million in 2013 and will expand at a Compound Annual Growth Rate (CAGR) of 6.4% to reach just under $1.24 billion by 2020, according to the new report on ASDReports.

The company‟s latest report* states that while most orthopedic markets were hit hard by the economic downturn in the past five years, the CMF space, which covers plate and screw fixation, distraction, cranial flap fixation, temporomandibular joint (TMJ) replacement, CMF bone graft substitutes, and thoracic fixation, will witness stable growth over the forecast period.

Linda Tian, MSc, GlobalData‟s Analyst covering Medical Devices, says: “Lingering economic concerns in the US have significantly impacted hospital budgets and resulted in downward pricing pressures, limiting market growth.

“US healthcare providers and regulatory authorities are implementing cost-containment policies, incorporating so-called „appropriateness criteria‟ into treatment guidelines.
This leads to the delayed adoption of premium CMF devices, such as patient-specific implants.

”Despite this, the report expects that heightened patient awareness, coupled with the supply side‟s efforts in product line extensions and medical training, will help to accelerate US surgeons‟ adoption of advanced technologies, such as virtual surgical planning for reconstructive and orthognathic surgeries.

Tian continues: “The US is a particularly lucrative market due to increasingly higher CMF procedure volumes, boosted by the non-elective nature of a significant portion of CMF surgeries.

“Besides increased patient awareness, key drivers of this include a trend towards early surgical intervention in younger patients, expanded insurance coverage under the Affordable Care Act, and domestic manufacturers‟ continuous implant innovations.”

Of the various available technologies, CMF plate and screw fixation devices will remain the largest contributors to the US market, with their value forecast to rise from $587 million in 2013 to just over $895 million by 2020, representing a CAGR of 6.2%, says the report.

This report provides analysis of the craniomaxillofacial (CMF) devices market, covering CMF plate and screw fixation, CMF distraction, cranial flap fixation, temporomandibular joint (TMJ) replacement, CMF bone graft substitutes, and thoracic fixation (rigid fixation only). It includes annualized forecast data from 2013 to 2020 across six major markets, namely the US and five European countries (Germany, France, Spain, Italy and the UK).

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by a team of industry experts.